High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats

Spine

Volumn 36, Issue 25, 2011, Pages 2122-2129

  Chen, Ke Bing ^a,b   Uchida, Kenzo ^a   Nakajima, Hideaki ^a   Yayama, Takafumi ^a   Hirai, Takayuki ^a   Guerrero, Alexander Rodriguez ^a,c   Kobayashi, Shigeru ^a   Ma, Wei Ying ^a,b   Liu, Shao Yu ^a   Zhu, Ping ^a,d   Baba, Hisatoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b SUN YAT SEN UNIVERSITY   (China)

^c University of El Salvador   (El Salvador)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

high mobility group box 1 (HMGB 1); proinfl ammatory cytokine; receptor for advanced glycation end products (RAGE); spinal cord injury; toll like receptor (TLR)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; INFLAMMATION; MACROPHAGE; MALE; NERVE CELL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SPINAL CORD INJURY; THORACIC SPINAL CORD; TISSUE INJURY; TRANSCRIPTION REGULATION;

ACUTE-PHASE REACTION; ANIMALS; ANTERIOR HORN CELLS; CYTOKINES; FLUORESCENT ANTIBODY TECHNIQUE; HMGB1 PROTEIN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MICROSCOPY, IMMUNOELECTRON; NEURONS; PROTEIN BINDING; RATS; RECEPTORS, IMMUNOLOGIC; SPINAL CORD INJURIES; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81855163367     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318203941c     Document Type: Article

References (51)

1. Blight AR. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992; 9 ( suppl 1 ): S83-91.
2. Bartholdi D, Schwab ME. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study. Eur J Neurosci 1997; 9 : 1422-38.
3. Ito T, Oyanagi K, Wakabayashi K, et al. Traumatic spinal cord injury: A neuropathological study on the longitudinal spreading of the lesions. Acta Neuropathol 1997; 93 : 13-8.
4. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994; 6 : 712-24.
5. Hayashi M, Ueyama T, Nemoto K, et al. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 2000; 17 : 203-18.
6. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007; 500 : 267-85.
7. Nakamura M, Houghtling RA, MacArthur L, et al. Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 2003; 184 : 313-25.
8. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18 : 130-6.
9. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci 1996; 19 : 331-8.
10. Bethea JR, Dietrich WD. Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 2002; 15 : 355-60.
11. Inukai T, Uchida K, Nakajima H, et al. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse ( twy /twy ) sustaining chronic mechanical compression. Spine 2009; 34 : 2848-57.
12. Thomas JO. HMG1 and 2: Architectural DNA-binding proteins. Biochem Soc Trans 2001; 29 : 395-401.
13. Stros M, Ozaki T, Bacikova A, et al. HMGB1 and HMGB2 cellspecifically down-regulate the p53-and p73-dependent sequencespecific transactivation from the human Bax gene promoter. J Biol Chem 2002; 277 : 7157-64.
14. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279 : 7370-7.
15. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5 : 331-42.
16. Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1. J Leukoc Biol 2005; 78 : 1-8.
17. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192 : 565-70.
18. Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): An alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 2008; 10 : 209.
19. Chen G, Ward MF, Sama AE, et al. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res 2004; 24 : 329-33.
20. Wang H, Vishnubhakat JM, Bloom O, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126 : 389-92.
21. Kim JB, Sig Choi J, Yu YM, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006; 26 : 6413-21.
22. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993; 143 : 1699-712.
23. Vincent AM, Perrone L, Sullivan KA, et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007; 148 : 548-58.
24. Arancio O, Zhang HP, Chen X, et al. RAGE potentiates Abetainduced perturbation of neuronal function in transgenic mice. EMBO J 2004; 23 : 4096-105.
25. Anderson KV, Bokla L, Nüsslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the Toll gene product. Cell 1985; 42 : 791-8.
26. Popovich PG. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res 2000; 128 : 43-58.
27. Kigerl KA, Lai W, Rivest S, et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007; 102 : 37-50.
28. Nakajima H, Uchida K, Kobayashi S, et al. Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. J Neurotrauma 2007; 24 : 703-12.
29. Nakajima H, Uchida K, Yayama T, et al. Targeted retrograde gene delivery of brain-derived neurotrophic factor suppresses apoptosis of neurons and oligodendroglias after spinal cord injury in rats. Spine 2010; 35 : 497-504.
30. Uchida K, Baba H, Maezawa Y, et al. Increased expression of neurotrophins and their receptors in the mechanically compressed spinal cord of the spinal hyperostotic mouse ( twy /twy ). Acta Neuropathol 2003; 106 : 29-36.
31. Uchida K, Nakajima H, Inukai T, et al. Adenovirus-mediated retrograde transfer of neurotrophin-3 enhances survival of anterior horn neurons of twy /twy mice with chronic mechanical compression of the spinal cord. J Neurosci Res 2008; 86 : 1789-800.
32. Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 2001; 15 : 247-53.
33. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418 : 191-5.
34. Czura CJ, Tracey KJ. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med 2003; 31 ( suppl 1 ): S46-50.
35. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285 : 248-51.
36. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165 : 2950-4.
37. Wang H, Yang H, Czura CJ, et al. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001; 164 : 1768-73.
38. Dinarello CA. Interleukin-1. In: Thomson AW, ed. The Cytokine Handbook. 3rd ed. San Diego, CA : Academic Press, 1998 : 35-73.
39. Takao Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol 1998; 56 : 341-58.
40. Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22 : 5551-60.
41. Qiu J, Nishimura M, Wang Y, et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008; 28 : 927-38.
42. Muhammad S, Barakat W, Stoyanov S, et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008; 28 : 12023-31.
43. Stern D, Yan SD, Yan SF, et al. Receptor for advanced glycation end products: A multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002; 54 : 1615-25.
44. Yang H, Wang H, Czura CJ, et al. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 2002; 8 : 469-72.
45. Mackic JB, Stins M, McComb JG, et al. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 1998; 102 : 734-43.
46. Deane R, Du Yan S, Submamaryan RK, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003; 9 : 907-13.
47. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003; 284 : C870-9.
48. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 2000; 97 : 13766-71.
49. Zekki H, Feinstein DL, Rivest S. The clinical course of experimentalautoimmune encephalomyelitis is associated with a profound and sustained transcriptionalactivation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 2002; 12 : 308-19.
50. Ma li ska D, Laure-Kamionowska M, Ma li ski S. Toll-like receptors in rat brains injured by hypoxic-ischaemia or exposed to staphylococcalalpha-toxin. Folia Neuropathol 2004; 42 : 125-32.
51. Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of Tolllike receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 2005; 102 : 5856-61.